Cargando…

Deep Learning Driven Drug Discovery: Tackling Severe Acute Respiratory Syndrome Coronavirus 2

Deep learning significantly accelerates the drug discovery process, and contributes to global efforts to stop the spread of infectious diseases. Besides enhancing the efficiency of screening of antimicrobial compounds against a broad spectrum of pathogens, deep learning has also the potential to eff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yang, Ye, Taoyu, Xi, Hui, Juhas, Mario, Li, Junyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581544/ https://www.ncbi.nlm.nih.gov/pubmed/34777286 http://dx.doi.org/10.3389/fmicb.2021.739684

Ejemplares similares

Deep Learning-driven research for drug discovery: Tackling Malaria
por: Neves, Bruno J., et al.
Publicado: (2020)

Deep learning for microscopic examination of protozoan parasites
por: Zhang, Chi, et al.
Publicado: (2022)

Correction of out-of-focus microscopic images by deep learning
por: Zhang, Chi, et al.
Publicado: (2022)

Deep Learning Approach Based on Transcriptome Profile for Data Driven Drug Discovery
por: Kwon, Eun-Ji, et al.
Publicado: (2023)

Divide and conquer: processive transport enables multidrug transporters to tackle challenging drugs
por: Fluman, Nir, et al.
Publicado: (2014)

Mechanisms of Host Receptor Adaptation by Severe Acute Respiratory Syndrome Coronavirus
por: Wu, Kailang, et al.
Publicado: (2012)

Genomic representation predicts an asymptotic host adaptation of bat coronaviruses using deep learning
por: Li, Jing, et al.
Publicado: (2023)

Genomic pan-cancer classification using image-based deep learning
por: Ye, Taoyu, et al.
Publicado: (2021)

Rapid Scanning Electron Microscopy Detection and Sequencing of Severe Acute Respiratory Syndrome Coronavirus 2 and Other Respiratory Viruses
por: Haddad, Gabriel, et al.
Publicado: (2020)

Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Serological Diagnostic Tests and Antibody Kinetics in Coronavirus Disease 2019 Patients
por: Choi, Hyun-Woo, et al.
Publicado: (2022)

Comparison of the Performance of 24 Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Assays in the Diagnosis of Coronavirus Disease 2019 Patients
por: Wu, Shiji, et al.
Publicado: (2022)

Siderophores as “Trojan Horses”: tackling multidrug resistance?
por: de Carvalho, Carla C. C. R., et al.
Publicado: (2014)

Wrangling Shape-Shifting Morpheeins to Tackle Disease and Approach Drug Discovery
por: Jaffe, Eileen K.
Publicado: (2020)

Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro
por: Shionoya, Kaho, et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome
por: Chen, I-Yin, et al.
Publicado: (2019)

Impact of Prior Infection on Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in Syrian Hamsters
por: Zhang, Cheng, et al.
Publicado: (2021)

An Update on Animal Models for Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Countermeasure Development
por: Zhang, Liang, et al.
Publicado: (2021)

Delayed Antiviral Immune Responses in Severe Acute Respiratory Syndrome Coronavirus Infected Pregnant Mice
por: Zhu, Guohua, et al.
Publicado: (2022)

Tackling Multiple-Drug-Resistant Bacteria With Conventional and Complex Phytochemicals
por: Suganya, Thangaiyan, et al.
Publicado: (2022)

Data-driven discovery of Green’s functions with human-understandable deep learning
por: Boullé, Nicolas, et al.
Publicado: (2022)

Deep Learning and Drug Discovery for Healthy Aging
por: Wang, Peter, et al.
Publicado: (2023)

Severe Acute Respiratory Syndrome Coronavirus 2: From Gene Structure to Pathogenic Mechanisms and Potential Therapy
por: Wu, Jun, et al.
Publicado: (2020)

Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibodies in Egyptian Convalescent Plasma Donors
por: Gomaa, Mokhtar R., et al.
Publicado: (2020)

Emerging Severe Acute Respiratory Syndrome Coronavirus 2 Mutation Hotspots Associated With Clinical Outcomes and Transmission
por: Pang, Xianwu, et al.
Publicado: (2021)

Functional Severe Acute Respiratory Syndrome Coronavirus 2 Virus-Like Particles From Insect Cells
por: Naskalska, Antonina, et al.
Publicado: (2021)

Suppression and Activation of Intracellular Immune Response in Initial Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Jia, Lijia, et al.
Publicado: (2021)

Molecular Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 Isolates From Central Inner Sardinia
por: Malune, Paolo, et al.
Publicado: (2022)

Pseudotyped Vesicular Stomatitis Virus-Severe Acute Respiratory Syndrome-Coronavirus-2 Spike for the Study of Variants, Vaccines, and Therapeutics Against Coronavirus Disease 2019
por: Salazar-García, Marcela, et al.
Publicado: (2022)

Machine Learning Approaches for Tackling Novel Coronavirus (COVID-19) Pandemic
por: Rahman, Mohammad Marufur, et al.
Publicado: (2021)

CoronaVR: A Computational Resource and Analysis of Epitopes and Therapeutics for Severe Acute Respiratory Syndrome Coronavirus-2
por: Gupta, Amit Kumar, et al.
Publicado: (2020)

A Case Report: Genetically Distinct Severe Acute Respiratory Syndrome Coronavirus-2 Variant Causing Reinfection
por: Hossain, Mohammad Enayet, et al.
Publicado: (2021)

Assessing the Mobility of Severe Acute Respiratory Syndrome Coronavirus-2 Spike Protein Glycans by Structural and Computational Methods
por: Stagnoli, Soledad, et al.
Publicado: (2022)

Recent Advances in Aptamer Discovery and Applications
por: Zhang, Yang, et al.
Publicado: (2019)

Is Pakistan prepared to tackle the coronavirus epidemic?
por: Saqlain, Muhammad, et al.
Publicado: (2020)

Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor
por: Peng, Guiqing, et al.
Publicado: (2017)

Deep Learning-Driven Library Design for the De Novo Discovery of Bioactive Thiopeptides
por: Chang, Jun Shi, et al.
Publicado: (2023)

Phosphatidylinositol 4-Kinase IIIβ Is Required for Severe Acute Respiratory Syndrome Coronavirus Spike-mediated Cell Entry
por: Yang, Ning, et al.
Publicado: (2012)

Elastase-mediated Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein at Discrete Sites within the S2 Domain
por: Belouzard, Sandrine, et al.
Publicado: (2010)

Host- and Species-Dependent Quasispecies Divergence of Severe Acute Respiratory Syndrome Coronavirus-2 in Non-human Primate Models
por: Hwang, Eun-Ha, et al.
Publicado: (2021)

Challenging the Drug-Likeness Dogma for New Drug Discovery in Tuberculosis
por: Machado, Diana, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_uuqt72lrto9gtbc9tfba10637k